Antu Eapan Thomas
Stock Analyst at Geojit Research
(1.02)
# 3,905
Out of 5,000 analysts
44
Total ratings
38.5%
Success rate
-2.5%
Average return
Main Sectors:
Stocks Rated by Antu Eapan Thomas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: MANKIND Mankind Pharma Limited | Reiterated: Buy | ₹2,660 | ₹2,490 | +6.83% | 1 | Jun 16, 2026 | |
| NSE: FORTIS Fortis Healthcare Limited | Reiterated: Buy | ₹1,150 | ₹856.40 | +34.28% | 1 | Jun 15, 2026 | |
| NSE: PVRINOX PVR INOX Limited | Reiterated: Buy | ₹1,065 → ₹1,189 | ₹1,264 | -5.92% | 2 | Jun 5, 2026 | |
| NSE: RAINBOW Rainbow Children's Medicare Limited | Initiated Coverage: Buy | ₹1,679 | ₹1,391 | +20.68% | 1 | May 27, 2026 | |
| NSE: SBICARD SBI Cards and Payment Services Limited | Reiterated: Buy | ₹950.00 → ₹698.00 | ₹617.25 | +13.08% | 2 | May 18, 2026 | |
| NSE: LICI Life Insurance Corporation of India | Reiterated: Buy | ₹544.00 → ₹467.00 | ₹404.85 | +15.35% | 3 | Mar 18, 2026 | |
| NSE: NBCC NBCC (India) Limited | Rated: Hold | n/a | $82.17 | - | 1 | Mar 17, 2026 | |
| NSE: GODREJPROP Godrej Properties Limited | Reiterated: Buy | ₹2,096 | ₹1,691 | +23.99% | 1 | Feb 26, 2026 | |
| NSE: AMBER Amber Enterprises India Limited | Initiated Coverage: Buy | ₹9,156 | ₹6,960 | +31.55% | 1 | Feb 23, 2026 | |
| NSE: HCG HealthCare Global Enterprises Limited | Upgraded: Buy | ₹628.00 → ₹724.00 | ₹699.10 | +3.56% | 2 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹780.00 | ₹783.70 | -0.47% | 1 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,180 | ₹1,028 | +14.75% | 1 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹568.00 → ₹791.00 | ₹266.15 | +197.20% | 3 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹686.00 | ₹514.35 | +33.37% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹4,409 → ₹4,560 | ₹3,865 | +17.98% | 2 | Feb 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹857.00 → ₹828.00 | ₹522.10 | +58.59% | 4 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹2,244 → ₹2,080 | ₹1,576 | +31.96% | 2 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹312.00 → ₹439.00 | ₹384.45 | +14.19% | 2 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ₹1,076 | ₹982.20 | +9.55% | 1 | Jan 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,085 | ₹1,200 | -9.55% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹2,254 | ₹1,746 | +29.09% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,790 → ₹1,613 | ₹1,543 | +4.51% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,015 | ₹741.05 | +36.97% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,820 | ₹1,224 | +48.75% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,791 → ₹1,247 | ₹457.75 | +172.42% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹3,691 | ₹2,077 | n/a | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹386.00 | ₹138.80 | n/a | 1 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹2,770 | ₹1,014 | n/a | 1 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹326.00 | ₹308.55 | n/a | 1 | Dec 10, 2024 |
Mankind Pharma Limited
Jun 16, 2026
Reiterated: Buy
Price Target: ₹2,660
Current: ₹2,490
Upside: +6.83%
Fortis Healthcare Limited
Jun 15, 2026
Reiterated: Buy
Price Target: ₹1,150
Current: ₹856.40
Upside: +34.28%
PVR INOX Limited
Jun 5, 2026
Reiterated: Buy
Price Target: ₹1,065 → ₹1,189
Current: ₹1,264
Upside: -5.92%
Rainbow Children's Medicare Limited
May 27, 2026
Initiated Coverage: Buy
Price Target: ₹1,679
Current: ₹1,391
Upside: +20.68%
SBI Cards and Payment Services Limited
May 18, 2026
Reiterated: Buy
Price Target: ₹950.00 → ₹698.00
Current: ₹617.25
Upside: +13.08%
Life Insurance Corporation of India
Mar 18, 2026
Reiterated: Buy
Price Target: ₹544.00 → ₹467.00
Current: ₹404.85
Upside: +15.35%
NBCC (India) Limited
Mar 17, 2026
Rated: Hold
Price Target: n/a
Current: $82.17
Upside: -
Godrej Properties Limited
Feb 26, 2026
Reiterated: Buy
Price Target: ₹2,096
Current: ₹1,691
Upside: +23.99%
Amber Enterprises India Limited
Feb 23, 2026
Initiated Coverage: Buy
Price Target: ₹9,156
Current: ₹6,960
Upside: +31.55%
HealthCare Global Enterprises Limited
Feb 19, 2026
Upgraded: Buy
Price Target: ₹628.00 → ₹724.00
Current: ₹699.10
Upside: +3.56%
Feb 19, 2026
Reiterated: Buy
Price Target: ₹780.00
Current: ₹783.70
Upside: -0.47%
Feb 16, 2026
Upgraded: Buy
Price Target: ₹1,180
Current: ₹1,028
Upside: +14.75%
Feb 11, 2026
Reiterated: Buy
Price Target: ₹568.00 → ₹791.00
Current: ₹266.15
Upside: +197.20%
Feb 10, 2026
Reiterated: Buy
Price Target: ₹686.00
Current: ₹514.35
Upside: +33.37%
Feb 1, 2026
Reiterated: Buy
Price Target: ₹4,409 → ₹4,560
Current: ₹3,865
Upside: +17.98%
Jan 29, 2026
Reiterated: Buy
Price Target: ₹857.00 → ₹828.00
Current: ₹522.10
Upside: +58.59%
Jan 28, 2026
Reiterated: Buy
Price Target: ₹2,244 → ₹2,080
Current: ₹1,576
Upside: +31.96%
Jan 2, 2026
Upgraded: Buy
Price Target: ₹312.00 → ₹439.00
Current: ₹384.45
Upside: +14.19%
Jan 1, 2026
Downgraded: Hold
Price Target: ₹1,076
Current: ₹982.20
Upside: +9.55%
Nov 11, 2025
Upgraded: Buy
Price Target: ₹1,085
Current: ₹1,200
Upside: -9.55%
Nov 10, 2025
Reiterated: Buy
Price Target: ₹2,254
Current: ₹1,746
Upside: +29.09%
Nov 7, 2025
Reiterated: Buy
Price Target: ₹1,790 → ₹1,613
Current: ₹1,543
Upside: +4.51%
Oct 31, 2025
Reiterated: Buy
Price Target: ₹1,015
Current: ₹741.05
Upside: +36.97%
Oct 31, 2025
Upgraded: Buy
Price Target: ₹1,820
Current: ₹1,224
Upside: +48.75%
Oct 8, 2025
Reiterated: Buy
Price Target: ₹1,791 → ₹1,247
Current: ₹457.75
Upside: +172.42%
Jul 15, 2025
Reiterated: Buy
Price Target: ₹3,691
Current: ₹2,077
Upside: n/a
Jun 9, 2025
Reiterated: Buy
Price Target: ₹386.00
Current: ₹138.80
Upside: n/a
Apr 2, 2025
Reiterated: Hold
Price Target: ₹2,770
Current: ₹1,014
Upside: n/a
Dec 10, 2024
Reiterated: Hold
Price Target: ₹326.00
Current: ₹308.55
Upside: n/a